News

Find News

Filter articles

Applied Filters

Showing 41 to 50 of 700 results

GSK and Chinese biotech unite for coronavirus vaccine development

China, UK25-02-2020Sarah Morgan

British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate.

Sanofi partners with HHS to work on COVID-19 vaccine

France, US19-02-2020Sarah Morgan

Sanofi’s vaccine unit has united with the US Department of Health and Human Services to develop a vaccine for the COVID-19 virus, which has so far killed more than 2,000 people worldwide.

Eli Lilly claims another victory in Taltz patent battle

UK18-02-2020Rory O'Neill

The English High Court has invalidated key claims of a patent owned by Roche subsidiary Genentech, following a lawsuit filed by US rival Eli Lilly.

University of California gains ground after EPO backs CRISPR patent

EU11-02-2020Sarah Morgan

In a victory for the University of California, the European Patent Office has affirmed a CRISPR patent issued to Emmanuelle Charpentier, the University of California, and the University of Vienna.

EIP boosts medtech practice with HGF partner

UK11-02-2020

Gareth Probert, the former head of HGF’s Nottingham, UK office, has joined EIP to strengthen its medtech and healthcare practice.

Canadian cannabis brand blocked from UK TM registration

UK07-02-2020Rory O'Neill

The UK Intellectual Property Office has blocked Canadian brand Vivo Cannabis from registering ‘Lumina’ as a trademark, after an opposition from an Italian pharmaceutical company.

CIPA and UKIPO join forces to change misleading Brexit advice

EU, UK03-02-2020Sarah Morgan

The UK Intellectual Property Office and the Chartered Institute of Patent Attorneys have worked together to ensure changes are made to “misleading” advice issued by the EU’s Community Plant Variety Office.

CJEU issues clarification on UK’s pay-for-delay generics ruling

EU31-01-2020Edward Pearcey

The Court of Justice of the European Union has ruled that pharmaceutical pay-for-delay agreements may violate the Treaty on the Functioning of the European Union, in comments passed down on January 30, 2020.

Bristows hires Arnold & Porter partner to boost life sciences team

UK28-01-2020Sarah Morgan

Arnold & Porter partner Richard Dickinson has joined Bristows as a partner in its commercial and IP transactional practice in London.

GSK’s Seroxat pay-for-delay deals may restrict competition: AG

EU23-01-2020Sarah Morgan

GlaxoSmithKline may have restricted competition by making a deal with generic drugmakers to delay the launch of copies of an antidepressant, according to an adviser to the Court of Justice of the European Union.

Showing 41 to 50 of 700 results

LSIPR